CURTIS LONG: Open Payments
NPI 1588181481 · NORTH LIBERTY, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$673 in 37 payments from 12 companies in 2025. Trend: 2023 $44 · 2024 $252 · 2025 $673
Food & beverage: $673
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $152 |
| Otsuka America Pharmaceutical, Inc. | 5 | $113 |
| Axsome Therapeutics, Inc. | 5 | $108 |
| Vanda Pharmaceuticals Inc. | 3 | $94 |
| Collegium Pharmaceutical, Inc. | 3 | $54 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| Lundbeck LLC | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
| Alkermes, Inc. | 1 | $19 |
Products named: VRAYLAR, REXULTI, Auvelity, FANAPT, Jornay PM, CAPLYTA, TRINTELLIX, Qelbree.
Industry payments across IA — which companies pay providers there.
